The pharmaceutical supply chain is under growing pressure across Europe. Rising energy prices, labor shortages, regulatory costs, and supply disruptions have significantly increased medicine production expenses. Ukraine, in particular, is facing serious challenges in maintaining affordable and uninterrupted capsule manufacturing. This has led many Ukrainian importers, distributors, and healthcare buyers to explore alternative sourcing markets.